We now expect an annual EBITDA of €3.5m (vs €4m previously) for this period and anticipate a return to generating operating cash flow of about €1.2m, primarily due to cost reductions. On one hand, these data would highlight a NFP/EBITDA ratio of 4.5x expected by year- end, but on the other hand, this would be achieved with only 2.5% organic revenue growth. We believe that 2025 could be the year of actual recovery for the company, with an expected growth of 17% (+€4.5m). In this context, the company's EBITDA could reach €6.9m (vs €7.5m previously estimated), a figure that could mark the end of the turnaround period, closely linked to the company's growth capacity.